Clinical trial
Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given…
NCT00158756 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00158756 |
|---|---|
| Title | Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants |
| Official title | A Phase III, Partially Blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Tritanrix™-HepB and GSK Biologicals Kft's DTPw-HBV Vaccines as Compared to Concomitant Administration of Commonwealth Serum Laboratory's (CSL's) DTPw (Triple… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Biological, Drug |
| Interventions | Tritanrix™-HepB, Rotarix™, Zilbrix™, Triple Antigen™, Engerix™-B, Placebo |
| Enrollment | 308 |
| Start date | Sep 12, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 23, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 6, 2018 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: